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Objectives: Carriers of the C677T have both altered folate metabolism 
and higher risk of cancers, including breast cancer. Supplementation is 
thought to correct his imbalance, but high intakes of synthetic folic acid 
increase blood concentrations of unmetabolized folic acid (UFA) with 
unknown implications on breast cancer risk, particular among those with 
altered folate metabolism. This study assesses the association between 
plasma UFA and breast cancer among MTHFR C677T genotypes. 
Methods: In this hospital-based case-control study, 150 adult women 
with confirmed history of breast cancer were age-matched to 150 adult 
female controls. Blood concentration of unmetabolized folic acid was 
determined via fasting venous blood samples and the effects of UFA on 
breast cancer incidence were assessed by conditional logistic regression. 
Results: Stratified by genotype, we expect a small but statistically 
significant increased odds ratio associated with higher UFA among 
homozygous MTHFR C677T polymorphs and a non-statistically 
significant association among heterozygous genotypes between 
UFA and breast cancer risk. We expect to find no association of 




The U.S. folic acid enrichment program has been effective in raising 
population average levels of folate intake and, as a consequence, in 
reducing incidence of neural tube defects (NTD). But, within a few years, 
folate intake in the population far exceeded the amount estimated prior to 
implementing the folic acid enrichment program and evaluated for safety. 
Though it was generally believed these high intakes of folic acid were 
relatively harmless, research increasingly shows that folate plays a 
complex and potentially dual role in cancer: where too little may increase 
risk for carcinogenesis, but excessive levels may promote cancer growth.
Given that women of child-bearing age are the primary target of folic acid 
enrichment, this potential role of folate in breast cancer has been 
increasingly investigated among carriers of the common MTHFR C677T 
mutation, present in upwards of 40% of the population. However, few of 
these studies have sought to illuminate the potential differing affects of 
natural versus synthetic folate. As unmetabolized folic acid is almost 
exclusively a function of folic acid intake, the present study hopes to 
demonstrate whether high folic acid intake is associated with breast cancer 
in MTHFR C677T polymorphs through the association between UFA and 
breast cancer among the genotypes. 
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Participants
A cohort of 150 adult females with histologically confirmed breast 
cancer will be recruited via advertisement and referral at three 
breast cancer clinics; one in Washington, D.C., Maryland, and 
Virginia. 150 adult female controls, without a history of breast 
cancer will be recruited via advertisement placed in adjoining 
hospitals. 
Participants who complete the full questionnaire, interview, and 
provide a blood sample will then receive explanation of 
compensation and reimbursement for their participation in the 
study. Participants will be provided $80.00 USD for both days of 
participation, reimbursement of travel costs to and from the 
hospital (up to $20.00 per day for roundtrip costs), with an 
additional $50.00 USD upon the provision of the blood sample. 
Results
Quantitative data from the study are the plasma UFA levels 
stratified by genotype and breast cancer status. Differences in 
characteristics of cases and controls will be analyzed using a 
Student’s t-test while distribution of covariates will be tested via 
Chi-square test. Analyses for the interaction of genotype and UFA 
with breast cancer will be stratified by genotype (CC, CT, TT) and 
odds ratio (and 95% confidence interval) for breast cancer in 
relation to UFA calculated with conditional logistic regression to 
preserve matching.
Participants for the case population will be recruited by advertisement and 
provider reference at three breast cancer clinics in the D.C. metropolitan 
area while controls will be recruited by advertisement at adjoining hospital 
centers. Subjects will be excluded if they are currently pregnant, lactating, 
taking any medication or undergoing any treatment that might interfere 
with folate metabolism. For the control population, additional exclusion 
criteria is a history of breast cancer. 
Recruited subjects will undergo a brief interview with a healthcare 
professional to ascertain biometrics (age, weight, height, race, menopausal 
status), medical history, reproductive data, and potential confounding 
variables (e.g. alcohol consumption). After 8 hours of fasting or more, 
subjects will provide venous blood samples from which genotyping and 
UFA may be measured.  
By correlating UFA concentrations with breast cancer incidence in the 
MTHFR genotypes, this study aims to illustrate the potential differing 
affects that synthetic folate (folic acid) may have on breast cancer risk in 
women with altered folate metabolism via the MTHFR mutation, as 
compared with the risks posed by elevated folate intake from dietary 
sources. 
Worldwide distribution of MTHFR C677T T-allele 2 MTHFR Activity in brain extract of folic acid supplemented mice 3
The Folate Metabolism Cycle 
Prevalence of UFA in relation to FA intake 4
Discussion
It is expected that this cohort study will show a small, but 
statistically significant association between UFA and breast cancer 
among homozygous (TT) MTHFR C677T genotypes and a non-
significant association among heterozygous (CT) types. 
Such results provide evidence of potential harm from very elevated 
intakes of synthetic folates among carriers of this mutation and 
would warrant further investigation into risks associated with folic 
acid supplementation, renewed scrutiny of the safety of mandatory 
folic acid enrichment, and research into the possible suitability of 
substituting synthetic folic acid with natural 5-MTHF in enrichment 
and supplementation programs.  
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